Immune Response
Transforming vaccine manufacture to increase access to vaccinations through speed, cost and more sustainable vaccines supply chain.
FACILITATED BY
SARAH GOULDING | Challenge Director | UKRI Industrial Strategy Challenge Fund in Medicines Manufacturing
PANELLISTS INCLUDE
MATTHEW DUCHARS | Chief Executive Officer | Vaccines Manufacturing & Innovation Centre
DAVID HIPKISS | Chief Executive Officer | Enesi Pharma
IAN MUIR | Chief Executive Officer | Porton Biopharma